pteridines has been researched along with Ewing Sarcoma in 3 studies
Excerpt | Relevance | Reference |
---|---|---|
"These findings support the further exploration of volasertib for pediatric malignancies, particularly alveolar rhabdomyosarcoma, and its combination with mitotic spindle poison." | 3.83 | Polo-like Kinase Inhibitor Volasertib Exhibits Antitumor Activity and Synergy with Vincristine in Pediatric Malignancies. ( Abbou, S; Daudigeos-Dubus, E; Geoerger, B; Lanvers-Kaminsky, C; Laplace-Builhe, C; LE Dret, L; Molenaar, J; Vassal, G, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zuco, V | 1 |
De Cesare, M | 1 |
Zaffaroni, N | 1 |
Lanzi, C | 1 |
Cassinelli, G | 1 |
Weiß, LM | 1 |
Hugle, M | 1 |
Romero, S | 1 |
Fulda, S | 1 |
Abbou, S | 1 |
Lanvers-Kaminsky, C | 1 |
Daudigeos-Dubus, E | 1 |
LE Dret, L | 1 |
Laplace-Builhe, C | 1 |
Molenaar, J | 1 |
Vassal, G | 1 |
Geoerger, B | 1 |
3 other studies available for pteridines and Ewing Sarcoma
Article | Year |
---|---|
PLK1 is a critical determinant of tumor cell sensitivity to CPT11 and its inhibition enhances the drug antitumor efficacy in squamous cell carcinoma models sensitive and resistant to camptothecins.
Topics: Activation, Metabolic; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Camptothe | 2015 |
Synergistic induction of apoptosis by a polo-like kinase 1 inhibitor and microtubule-interfering drugs in Ewing sarcoma cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Bone Neoplasms; Cell C | 2016 |
Polo-like Kinase Inhibitor Volasertib Exhibits Antitumor Activity and Synergy with Vincristine in Pediatric Malignancies.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Bone Neoplasm | 2016 |